Menu

Oramed Pharmaceuticals Inc.

Complementary equity research reports on Oramed Pharmaceuticals Inc.

Report Type

Publish Date

link

2019 Annual Update

2 December 2019

2019 Annual Update – Hebrew Appendix

2 December 2019

Q3 2019 Report

30 July 2019

Q3 2019 Report – Hebrew Appendix

30 July 2019

Q2 2019 Report

6 May 2019

Q2 2019 Report – Hebrew Appendix

6 May 2019

Q1 2019 Report

27 January 2019

Q1 2019 Report – Hebrew Appendix

27 January 2019

Initiation of Coverage 2

31 December 2018

Initiation of Coverage 2 – Hebrew Appendix

31 December 2018

Report for the Quarter ending 31 May, 2018

24 July 2018

Report for the Quarter ending 31 May, 2018 – Hebrew Appendix

24 July 2018

Report for the Quarter ending 28 February, 2018

29 April 2018

Report for the Quarter ending 28 February, 2018 – Hebrew Appendix

29 April 2018

Initiation of Coverage

23 December 2017

Initiation of Coverage – Hebrew Appendix

23 December 2017

Have Questions?

We have Answers.

Schedule a Complimentary Growth Strategy
Dialogue with an Industry Expert

877.GoFrost

(877.463.7678)

myfrost@frost.com

COVID-19 Growth Pipeline Diagnostic™

In less than 15 minutes, you will be provided insight to more accurately assess your company.

This Covid-19 Growth Pipeline Diagnostic™ will provide you with a benchmark on how well your company is prepared to grow in the future. The ten questions are based on best practices of the top 10% of companies that consistently achieve their growth potential.

X